TMO
THERMO FISHER SCIENTIFIC INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$679.38
−1.54%Jul 22, 2026, 06:32 UTC
ImmuPharma PLC appointed Thermo Fisher Scientific to develop and manufacture the finished form of its experimental diabetes treatment Kapiglucagon.
Jul 15, 2026, 15:45 UTC
San Diego Zoo Wildlife Alliance appointed Annie Fitzgerald as chief operating officer and Allyson Carr as chief human resources officer.
Source:Jul 7, 2026, 12:30 UTC
Thermo Fisher Scientific received FBI approval for its RapidINTEL Plus Cartridge to generate DNA profiles eligible for national CODIS searches.
Source:Jul 2, 2026, 11:00 UTC
Arcturus Therapeutics announced a strategic collaboration with Thermo Fisher Scientific to support Phase 3 development and potential commercialization of ARCT-032 for cystic fibrosis.
Source:Jul 2, 2026, 00:00 UTC
Arcturus Therapeutics signed a Master Services Agreement with Thermo Fisher Scientific for development services for ARCT-032, an mRNA therapeutic for cystic fibrosis, with Thermo Fisher contributing up to $40 million in clinical manufacturing services and Arcturus engaging PPD for up to $40 million in CRO services.
Jun 29, 2026, 08:07 UTC
genedrive PLC signed a collaboration agreement with Thermo Fisher Scientific to develop a high-throughput laboratory test.
Source:Jun 16, 2026, 00:00 UTC
GeneDx Holdings Corp. appointed Mark Gardner as President, effective June 15, 2026.
Source:Jun 1, 2026, 12:30 UTC
Thermo Fisher Scientific expanded its Orbitrap mass spectrometry platforms, AI-enabled software and integrated workflows at the ASMS 2026 conference.
Source:
← PreviousPage 2